COMMUNIQUÉS West-GlobeNewswire

BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
30/11/2017
MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and [...]
TearLab Launches Registered Direct Offering
30/11/2017
SAN DIEGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced that it is launching a registered direct offering to raise gross proceeds of [...]
Symphony Health Launches New Long Term Care Channel Offering
30/11/2017
CONSHOHOCKEN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Symphony Health , a PRA Health Sciences company and a leading provider of data, cloud-based analytics and consulting solutions to life science companies and [...]
Scythian Biosciences Corp. Completes Sale of Go Green
30/11/2017
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC Pink:SCCYF) is pleased to announce that it has entered into a share purchase [...]
TOMI Environmental Solutions, Inc. Joins Forces With Protak Scientific in Ground Breaking Partnership
30/11/2017
BEVERLY HILLS, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]
RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea
30/11/2017
Glen Rock, N.J, Nov. 30, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”) announces that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic [...]
PDMR Dealing
30/11/2017
LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
30/11/2017
BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV testing-related [...]
Industry Veteran Dr. Meqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.
30/11/2017
ORANGE COUNTY, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCBB: GLAG ) today announced that it has promoted Dr. Meqsood Rehman, 41, to the Chief Executive Officer of Gala Global, Inc., taking over [...]
SeaSpine Announces FDA 510(k) Clearance of OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh
30/11/2017
CARLSBAD, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4
30/11/2017
NOVATO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced [...]
Targovax ASA: New member of the board of directors
30/11/2017
Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the extraordinary general meeting of Targovax [...]
Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors
30/11/2017
HAMPTON, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX ) announced today that enrollment has opened in its open-label, Phase 1 study of CDX-1140 in patients with advanced solid tumors [...]
Achaogen to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference
30/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
Cancer Genetics to Participate in Upcoming Investor Conferences
30/11/2017
RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that the [...]
BIOLIFE4D Selects FischTank Marketing and PR as Agency of Record
30/11/2017
CHICAGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has retained FischTank Marketing and [...]
Hooper Holmes Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017
30/11/2017
OLATHE, Kan., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW) today announced that, Henry Dubois, Chief Executive Officer, and Mark Clermont, President, will be featured presenters at the LD Micro 10 [...]
Portola Pharmaceuticals to Present New Data on Betrixaban, Andexanet Alfa and Cerdulatinib at the 59th American Society of Hematology (ASH) Annual Meeting
30/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that new data on the Company’s first FDA-approved anticoagulant, betrixaban, and its two [...]
HempAmericana Inc. Executes Lease for High-Capacity CBD Oil Production Facility Site in Maine; Two-year Lease on Massive 17k Sq Ft Permit-Ready Facility Commences December 1
30/11/2017
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to announce that the Company has fully executed the lease for a 17,000-square foot state-of-the-art facility in [...]

Pages